Biomanufacturing is undergoing an explosion as new medicines, vaccines, materials and biofuels advance through development. Often companies face hurdles as they move from benchtop to production scale processes. This case study shows a region can creatively build a network of existing and new capabilities to help their emerging companies successfully transition to production scale as well as plant the seeds for growing their biomanufacturing industry. It will show how the Massachusetts iomanufacturing Center (a university, industry and government collaboration) is pooling skills and resources to help companies overcome the technical and workforce challenges in developing the biomanufacturing capabilities these new products require.

• Articulate the gap between Biomfg product needs and community capabilities in manufacturing
• Demonstrate new model of industry, government, university collaboration via a tightly coordinated, evolving network
• Highlight the focus emerging companies must place on biomanufacturing as well as clinical development